Study
Triple Negative Breast Cancer sequencing
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001000161 | Cancer Genomics |
Study Description
We propose to definitively characterise the somatic genetics of triple-ve breast cancer through generation of comprehensive catalogues of somatic mutations in a number of cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Study Datasets 5 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001000063 |
Triple Negative Breast Cancer sequencing
|
Illumina Genome Analyzer II | 6 |
EGAD00001000138 |
The expression data for this study can be found here: http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1088/and its SNP6 data can be found here:http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1087/
|
Illumina Genome Analyzer II,Illumina HiSeq 2000 | 58 |
EGAD00001001335 |
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
|
Illumina Genome Analyzer II,Illumina HiSeq 2000 | 28 |
EGAD00001001338 |
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
|
Illumina Genome Analyzer II,Illumina HiSeq 2000 | 49 |
EGAD00001002237 |
The disordered transcriptomes of cancer encompass direct effects of somatic mutation on transcription; co-ordinated secondary alterations in transcriptional pathways; and increased transcriptional noise. To catalogue the rules governing how somatic mutation Overall, 59% of 6980 exonic substitutions were expressed. Compared to other classes, nonsense mutations showed lower expression levels than expected with patterns characteristic of nonsense-mediated decay. 14% of 4234 genomic ... (Show More)
|
Illumina Genome Analyzer II,Illumina HiSeq 2000 | 59 |
Who archives the data?

Publications
Citations
Retrieving...

Retrieving...
